Arthralgias and myalgias related to quinupristin-dalfopristin administration.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 11181142.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study evaluated the frequency of and potential risk factors for arthralgias and/or myalgias associated with quinupristin-dalfopristin administration. Of 32 patients who received quinupristin-dalfopristin treatment, at least 15 (47%) developed arthralgias and/or myalgias. Clinicians should be aware of these adverse events associated with quinupristin-dalfopristin, which may occur more frequently than has been previously reported.
Medical subject headings
- Arthralgia
- Drug Therapy, Combination
- Muscular Diseases
- Virginiamycin